Bliss GVS Pharma Limited

NSE BLISSGVS.NS

Bliss GVS Pharma Limited Cash and Short-Term Investments for the year ending March 31, 2024: USD 16.88 M

Bliss GVS Pharma Limited Cash and Short-Term Investments is USD 16.88 M for the year ending March 31, 2024, a 23.72% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Bliss GVS Pharma Limited Cash and Short-Term Investments for the year ending March 31, 2023 was USD 13.65 M, a -28.97% change year over year.
Bliss GVS Pharma Limited Cash and Short-Term Investments for the year ending March 31, 2022 was USD 19.21 M, a 126.28% change year over year.
Bliss GVS Pharma Limited Cash and Short-Term Investments for the year ending March 31, 2021 was USD 8.49 M, a 60.06% change year over year.
Bliss GVS Pharma Limited Cash and Short-Term Investments for the year ending March 31, 2020 was USD 5.30 M, a -57.56% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

NSE: BLISSGVS.NS

Bliss GVS Pharma Limited

CEO	Mr. Gagan Harsh Sharma
IPO Date	July 26, 2010
Location	India
Headquarters	102, Hyde Park
Employees	831
Sector	Consumers Staples
Industries Personal Care Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Non-Alcoholic Beverages Perfumes & Fragrances Pharmaceuticals

Description

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India. It offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lotions, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, syrups, tablets, topical preparations, and transdermal patches. The company also provides other healthcare products, such as balms, creams, lotions, lozenges, nasal inhalers, over the counter products, petroleum jellies, powders, roll-ons, shampoos, soaps, solutions, sprays, syrups, and vaginal washes. In addition, it offers therapeutic products consisting of anti-bacterial, anti-dandruff shampoo, amino acid preparation, iron tonic, antitussive, appetite stimulant, anti-allergic, body supplement, anti-biotic, anti-diabetic, anti-diarrheal, anti-emetic, anti-fungal, anti-haemorrhoidal, anti-helmintic, anti-infective, anti-inflammatory, anti-malarial, anti-microbial, anti-migraine, anti-oxidant, anti-protozoal, ear wax solvent, anti-pyretic, anti-septic, anti-spasmodic, anti-ulcer, and anti-ulcerant; and analgesic, oral rehydration, antacid, anxiolytic, appetizer, cough syrup, erectile dysfunction, haematinic, hand sanitizer, health supplement, insecticide, laryngitis, pharyngitis, laxative, lubricant, mosquito repellant, nasal decongestant, nutritional supplement, moisturizer, prickly heat powder, skin lightening lotion, vaginal contraceptive, vaginal hygiene, and vitamin supplements, as well as medicated, complexion, moisturizing, and total protection soaps. The company also exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Key trends

Past 5 years